Kempen Capital Management N.V. Johnson & Johnson Transaction History

Kempen Capital Management N.V.

$9.59 Billion
Q3 2024

A detailed history of Kempen Capital Management N.V. transactions in Johnson & Johnson stock. As of the latest transaction made, Kempen Capital Management N.V. holds 965,122 shares of JNJ stock, worth $149 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

965,122

Previous 855,403 12.83%

Holding current value

$149 Million

Previous $125 Million 25.1%

% of portfolio

1.63%

Previous 1.42%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $16 Million - $18.4 Million	109,719 Added 12.83%	965,122 $156 Million
Q2 2024 Jul 24, 2024	BUY	$144.38 - $157.78 $17.7 Million - $19.3 Million	122,488 Added 16.71%	855,403 $125 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $2.44 Million - $2.56 Million	15,749 Added 2.2%	732,915 $116 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $32.1 Million - $35 Million	220,545 Added 44.41%	717,166 $112 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $13.8 Million - $15.5 Million	88,912 Added 21.81%	496,621 $77.3 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $61.6 Million - $73.5 Million	407,500 Added 194976.08%	407,709 $63.2 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $2,742 - $3,051	-17 Reduced 7.52%	209 $34,000
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $493,301 - $545,567	-2,933 Reduced 92.85%	226 $40,000
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $4.64 Million - $5.27 Million	-29,347 Reduced 90.28%	3,159 $560,000
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $480,888 - $533,562	-3,084 Reduced 8.67%	32,506 $5.56 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $958,825 - $1.07 Million	5,937 Added 20.02%	35,590 $5.75 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $260,749 - $279,699	1,635 Added 5.84%	29,653 $4.89 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $484,007 - $539,057	3,162 Added 12.72%	28,018 $4.61 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $371,019 - $425,870	2,706 Added 12.22%	24,856 $3.91 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $3.11 Million - $3.41 Million	22,150 New	22,150 $3.3 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $43,543 - $48,754	-343 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $27,016 - $29,713	-206 Reduced 37.52%	343 $48,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $69,020 - $76,744	549 New	549 $77,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.

Account

Kempen Capital Management N.V. Johnson & Johnson Transaction History